Patent details

93075 Product Name: Sacubitril et valsartan, sous forme de complexe sodique sacubitril valsartan, c'est-à-dire de [3-((1S,3R)-1-biphényl-4-ylméthyl-3-éthoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3'-méthyl-2-(pentanyol{2''-(tétrazol-5-ylate)biphényl-4'-ylméthyl}amino)butyrate] de trisodium hémipentahydraté

Basic Information

Publication number:
93075
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP068276898
Legal Status:
Invalid
Application number:
93075
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1058
Marketing Authorization Type:
Marketing Authorization Date:
23/11/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
18/05/2016
First Marketing Authorization date:
23/11/2015
Grant date:
Activation date:
Publication date:
02/06/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
28/06/2023
Annulment date:
Basic SPC Expiration:
23/11/2030
SPC Extension Expiration:
23/11/2030
Rejection date:
Withdrawal date:
08/06/2023

Owner

From:
18/05/2016
 
 

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/05/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LIU Yugang
Address:
United States (US)

2

Name:
HU Bin
Address:
United States (US)

3

Name:
BLACKLOCK Thomas, J.
Address:
United States (US)

4

Name:
SUTTON Paul, Allen
Address:
United States (US)

5

Name:
FENG Lili
Address:
United States (US)

6

Name:
GIRGIS Michael, J.
Address:
United States (US)

7

Name:
KARPINSKI Piotr
Address:
United States (US)

8

Name:
PRASHAD Mahavir
Address:
United States (US)

9

Name:
GODTFREDSEN Sven, Erik
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/08
Publication date:
13/07/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
VRV
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

3

Bulletin Heading:
VRV
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Other

Note:
(08/03/2022) Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
02/06/2020 Publication 1
07/01/2022 Outgoing Correspondence 1
09/03/2022 Outgoing Correspondence 1
08/03/2022 Incoming Correspondence (Post) 1
07/01/2022 Incoming Correspondence (Post) 1
15/06/2023 Outgoing Correspondence 1
08/06/2023 Incoming Correspondence (Post) 3